Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Hims & Hers turned in tremendous revenue and profitability growth in the fourth quarter. The company also issued very robust guidance. However, it will stop selling semaglutide-based weight-loss ...

While Hims offers more options for sexual health and hair loss, Roman offers more options overall. Here’s our full breakdown of Hims vs. Roman for erectile dysfunction, hair loss, and more.

They come in different ratios, or combinations, of active and inactive ingredients. The combination pill is more than 99 percent effective when taken as intended. The most common type of ...

Hims & Hers(NYSE: HIMS) stock was a heartening comeback story on Wednesday, following something of a rout earlier in the week. Several analysts raised their price targets on the specialty ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

Hims & Hers Health's latest twelve months ev/ebitda is 179.0x Hims & Hers Health's ev/ebitda decreased in 2023 (-27.8x, +113.6%) and increased in 2022 (-13.0x, -31.1%) and 2024 (179.0x, -743.6%).

In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands against other stocks that grow firmer despite mixed market sentiment. The stock market kicked off ...

The Food and Drug Administration announced that a shortage of medications Wegovy and Ozempic has been resolved; however, companies like Hims and Hers might have to stop selling compounded versions of ...

Hims & Hers stock fell by 27% as it announced plans to stop selling commercially available compounded semaglutide. The FDA removed semaglutide from its shortage list, affecting Hims & Hers' sales ...

Shares of Hims & Hers Health fell, dragged down by expectations that the telehealth-consultation platform will have to stop selling its weight-loss treatments, which boosted results in the fourth ...

(AbortionFinder provides an up-to-date guide to the legal landscape.) The abortion pill — really a two-drug regimen of mifepristone and misoprostol, taken 24 to 48 hours apart — allows people ...